VisualSonics demonstrates Vevo LAZR imaging system at AACR conference

September 20, 2017

"The Vevo LAZR photoacoustics system is a breakthrough in vivo imaging technology," said Anil Amlani, VisualSonics' President and CEO. "Advancements featured in this product will enable oncology researchers to accelerate their research into understanding the inner workings of the cancerous cell and the host tissue in which it resides. The ability to conduct this microscopic level research in a living organism, non-invasively and in real-time, will help our customers to turn groundbreaking science into lifesaving care at an even greater speed."

"The launch of the Vevo LAZR technology further demonstrates our commitment in providing game changing imaging technology to advance pre-clinical research," said Kevin M. Goodwin, SonoSite's President and CEO. "We are confident that the photoacoustics technology will provide never-before-seen insights into cancer research and will have a strong impact on the discovery of new therapeutics."

The Vevo LAZR system supports VisualSonics' continuous efforts to provide researchers with innovative solutions to improving pre-clinical research. Applications for the Vevo LAZR system range from lymph node imaging, study of hemoglobin and oxygen saturation, and targeted imaging of tumor biomarkers. In addition to cancer biology, this cutting-edge imaging system will benefit other areas of research such as diabetes, neurosciences, as well as developmental and reproductive biology.

Source: VisualSonics